Note: Ingredients listed on restricted chemical lists
EC/CAS
72869-86-4
Name of the chemical
11,14-Dioxa-2,9-diazaheptadec-16-enoic Acid, 4,4,6,16-tetramethyl-10,15-dioxo, 2-[(2-methyl-1-oxo-2-propenyl)oxy]ethyl ester (31)
Concentration
10-25% 5-10% ≤2.5%
General Information
Revision date
2023-12-10
Product name
Admira/Caps
1.2.2. Uses advised against
No further relevant information available
Icons in SDS
Company Information
company name
VOCO GmbH
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
OSHA Hazards Classification of the substance or mixture GHS07 Sensitization - Skin 1 H317 May cause an allergic skin reaction Additional information
Hazard pictograms
GHS07
Hazard statements
May cause an allergic skin reaction.
Precautionary statements
Wear protective gloves / protective clothing. If skin irritation or rash occurs: Get medical advice/attention. Dispose of contents/container in accordance with local/regional/national/international regulations.
Additional information
Use only for intended scope of application
PBT Substances
Not applicable
vPvB Substances
Not applicable
2.1 Classification of the substance or mixture
GHS07 Sensitization - Skin 1 H317 May cause an allergic skin reaction. ꞏ Additional information: This document has been prepared in accordance with the U.S. OSHA Hazard Communication Standard, which requires the inclusion of all known hazards of the product or ingredients regardless of the potential risk. The risks of the hazards communicated in this document may vary depending on the potential for exposure. Health effects are based on the unmixed/uncured material. Under FDA regulations this product is classified as a medical device. Medical devices are exempt from the labelling provisions of GHS according to the Hazard Communication Standard (HCS).
